GEN |
Genmab, de Deense parel
Kan iemand de link toesturen van de in het engels vertaalde Pro Investor Genmab Forum …...
|
Sleutel1 |
GEN |
Genmab, de Deense parel
Kan iemand de link naar de engelse variant van de Pro Investor Genmab Forum met mij delen …...
|
Sleutel1 |
GEN |
Genmab, de Deense parel
Company Announcement Net sales of DARZALEX ® in the third quarter of 2024 totaled USD 3.016 million Genmab receives royalties on worldwide net sales from Janssen Biotech, Inc. (Janssen) COPENHAGEN, De...
|
Sleutel1 |
GEN |
Genmab, de Deense parel
Genmab has its stock recommendation lowered to neutral by JPMorgan20/8 06:54Genmab has had its share recommendation lowered by financial house JPMorgan to neutral from &quo...
|
Sleutel1 |
GEN |
Genmab, de Deense parel
JPMs 10% downgrade may be a result of the gradual weakening of the USD, which most expect to continue in line with the interest rate cuts. This will affect Genmabs share price negatively in ...
|
Sleutel1 |
GEN |
Genmab, de Deense parel
Another one … BTIG analyst Kaveri Pohlman raised the price target on Genmab A/S (NASDAQ: GMAB) to $47.00 (from $46.00) while maintaining a Buy rating...
|
Sleutel1 |
GEN |
Genmab, de Deense parel
Fyi … UBS Remains a Buy on Genmab A/S Jun. 26, 2024, UBS analyst Xian Deng maintained a Buy rating on Genmab A/S today and set a price target of DKK2,750.00....
|
Sleutel1 |
GEN |
Genmab, de Deense parel
Hai Irene, weet je ook in welke size Genmab Board Member Anders Peters zijn holding heeft teruggebracht … uit persbericht van 11 juni blijkt dat hij maar slechts 2.000 aandelen heeft verkocht op gem....
|
Sleutel1 |
GEN |
Genmab, de Deense parel
Xian Deng from UBS: Genmab Buy DKK 2,750.00 Maintained Today...
|
Sleutel1 |
GEN |
Genmab, de Deense parel
From Nordeas morning commentary: Genmab (team) - Over the weekend, at the ASCO24 conference in Chicago, Genmab and BioNTech presented updated phase II data for acasunlimab (GEN1046), a PD-L1x4-1B...
|
Sleutel1 |
GEN |
Genmab, de Deense parel
DNB lowers PT Genmab from DKK 2,630 to DKK 2,600 Buy...
|
Sleutel1 |
GEN |
Genmab, de Deense parel
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-smal...
|
Sleutel1 |
GEN |
Genmab, de Deense parel
Beste Highlands, zou je deze ook met ons kunnen delen. Alvast bedankt!...
|
Sleutel1 |